Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 13, 2013

30071_dirs_2013-11-13_fbd15322-88d4-486f-9edb-cca8d3985924.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-11

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-11 ResMed Common Stock M 7143 $50.74 Acquired 30310.735 Direct
2013-11-11 ResMed Common Stock F 2685 $50.74 Disposed 27625.735 Direct
2013-11-11 ResMed Common Stock M 10000 $50.74 Acquired 37625.735 Direct
2013-11-11 ResMed Common Stock F 4336 $50.74 Disposed 33289.735 Direct
2013-11-11 ResMed Common Stock F 3005 $50.74 Disposed 30284.735 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-11 ResMed Performance RSU $0 M 7143 Disposed ResMed Common Stock (7143) Direct
2013-11-11 ResMed Performance RSU $0 M 10000 Disposed ResMed Common Stock (10000) Direct

Footnotes

F1: Only unvested RSUs expire on termination of employment.

F2: Includes 161.330 shares of stock purchased on October 31, 2013, pursuant to ResMed's Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/11/2010 and vested on 11/11/2013.

F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011 and vested on 11/11/2013.

F5: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012 and vested on 11/11/2013.